Literature DB >> 16378057

Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation.

Mahmut Ilker Yilmaz1, Mutlu Saglam, Kayser Caglar, Erdinc Cakir, Taner Ozgurtas, Alper Sonmez, Tayfun Eyileten, Mujdat Yenicesu, Cengizhan Acikel, Yusuf Oguz, Omer Ozcan, Ugur Bozlar, Kemal Erbil, Ismail Aslan, Abdulgaffar Vural.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with increased cardiovascular events. The relationships between the markers of inflammation and endothelial dysfunction were investigated both before and after living donor kidney transplantation.
METHODS: Twenty-seven renal transplant patients were studied. Eleven patients (six male, five female) were on cyclosporine A, whereas 16 patients (nine male, seven female) were treated with tacrolimus based regimes. Twenty-seven subjects (12 males, 15 females) were studied as controls. Plasma adiponectin, high sensitive C reactive protein (hsCRP), Asymetric dimethyl arginine (ADMA) levels were studied before transplantation and on days 1, 3, 7, 14, and 28. The brachial artery flow mediated dilatation (FMD) was studied before transplantation and on the 28th day.
RESULTS: Serum hsCRP and ADMA levels decreased significantly from the first posttransplantation day on each measurement (P<0.001 for all) while the decrement of plasma adiponectin started in the third day (P<0.001 for all). The FMD was lower in the patients than the control group (P<0.001) and improved significantly in the 28th day of transplantation (P<0.001).
CONCLUSIONS: The results indicate that ADMA is associated with FMD in CKD both before and after kidney transplantation. Endothelial functions improve at the very beginning of the posttransplantation period with accompanying reduction in ADMA and hsCRP levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378057     DOI: 10.1097/01.tp.0000183750.22675.be

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

Review 1.  Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.

Authors:  Xiaohong Liu; Xin Xu; Ruru Shang; Yingjie Chen
Journal:  Nitric Oxide       Date:  2018-06-19       Impact factor: 4.427

2.  Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure.

Authors:  Vikram Sharma; Gabriella A M Ten Have; Lars Ytrebo; Sambit Sen; Christopher F Rose; R Neil Dalton; Charles Turner; Arthur Revhaug; Hans M H van-Eijk; Nicolaas E P Deutz; Rajiv Jalan; Rajeshwar P Mookerjee; Nathan A Davies
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

3.  Asymmetric dimethylarginine and whole blood viscosity in renal failure.

Authors:  Mary S Hammes; Sydeaka Watson; Frederic L Coe; Faris Ahmed; Emily Beltran; Promila Dhar
Journal:  Clin Hemorheol Microcirc       Date:  2015       Impact factor: 2.375

4.  Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.

Authors:  Yosuke Suzuki; Hiroki Itoh; Fuminori Sato; Kanako Kawasaki; Yukie Sato; Takashi Fujioka; Yuhki Sato; Keiko Ohno; Hiromitsu Mimata; Satoshi Kishino
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

Review 5.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

6.  Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients.

Authors:  Aysegul Kudu Cobanoglu; Ozkan Gungor; Fatih Kircelli; Ekrem Altunel; Gulay Asci; Sureyya Suha Ozbek; Huseyin Toz; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2012-12-05       Impact factor: 2.370

7.  Impact of fish intake on oxidative stress when included into a moderate energy-restricted program to treat obesity.

Authors:  Dolores Parra; Narcisa M Bandarra; Mairead Kiely; Inga Thorsdottir; J Alfredo Martínez
Journal:  Eur J Nutr       Date:  2007-11-17       Impact factor: 5.614

Review 8.  Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review.

Authors:  Johannes Jacobi; Philip S Tsao
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

9.  Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

Authors:  Edzard Schwedhelm; Renke Maas; Ralf Freese; Donald Jung; Zoltan Lukacs; Alen Jambrecina; William Spickler; Friedrich Schulze; Rainer H Böger
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

Review 10.  Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Authors:  Luis Aldámiz-Echevarría; Fernando Andrade
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.